Home/Filings/4/0000899243-18-018711
4//SEC Filing

Ross Leonard S 4

Accession 0000899243-18-018711

CIK 0001314102other

Filed

Jun 28, 8:00 PM ET

Accepted

Jun 29, 4:01 PM ET

Size

9.1 KB

Accession

0000899243-18-018711

Insider Transaction Report

Form 4
Period: 2018-06-27
Ross Leonard S
Corporate Controller
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2018-06-276,66613,334 total
    Common Stock (6,666 underlying)
  • Tax Payment

    Common Stock

    2018-06-27$1.86/sh1,904$3,54114,762 total
  • Exercise/Conversion

    Common Stock

    2018-06-27+6,66616,666 total
Footnotes (3)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]On June 27, 2017, the reporting person was granted 20,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
  • [F3]No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the insider's exercise of his withholding right following the vesting of the restricted stock units.

Issuer

EyePoint Pharmaceuticals, Inc.

CIK 0001314102

Entity typeother

Related Parties

1
  • filerCIK 0001458753

Filing Metadata

Form type
4
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 4:01 PM ET
Size
9.1 KB